These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16515632)

  • 1. Recurrent ovarian dysgerminoma after laparoscopy.
    Prado S; Yazigi R; Garrido J; Gonzalez M; Torres R; Oddo D
    Int J Gynecol Cancer; 2006; 16 Suppl 1():397-9. PubMed ID: 16515632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian germ cell neoplasm in a true hermaphrodite.
    Mondal S; Chatterjee K; Bhattacharya SK; Nath SK
    J Indian Med Assoc; 2011 Nov; 109(11):832-3, 835. PubMed ID: 22666943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Hatch KD; Homesley HD
    J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity.
    Gershenson DM; Wharton JT; Kline RC; Larson DM; Kavanagh JJ; Rutledge FN
    Cancer; 1986 Dec; 58(12):2594-9. PubMed ID: 2430686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
    Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes.
    Takemori M; Ichimura T; Nishimura R; Hasegawa K
    Gynecol Obstet Invest; 2000; 49(3):211-3. PubMed ID: 10729765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian endodermal sinus tumor in a 76-year-old woman.
    Filiz G; Ozuysal S; Bilgin T
    J Obstet Gynaecol Res; 2003 Oct; 29(5):309-11. PubMed ID: 14641700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
    Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
    Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysgerminoma of the ovary.
    LaPolla JP; Benda J; Vigliotti AP; Anderson B
    Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced stage of dysgerminoma in testicular feminisation: is radical surgery necessary?
    Chan LY; Wong SF; Yu VS
    Aust N Z J Obstet Gynaecol; 2000 May; 40(2):224-5. PubMed ID: 10925918
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
    Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
    Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing teratoma syndrome: a case report and a review of the literature.
    Tangjitgamol S; Manusirivithaya S; Leelahakorn S; Thawaramara T; Suekwatana P; Sheanakul C
    Int J Gynecol Cancer; 2006; 16 Suppl 1():384-90. PubMed ID: 16515629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
    Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of complete response with radiation and chemotherapy using cisplatin, etoposide and bleomycin].
    Uekado Y; Touge H; Watanabe T; Inagaki T
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1865-8. PubMed ID: 7691042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
    Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
    J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian dysgerminoma: a case report and literature review.
    Ajao M; Vachon T; Snyder P
    Mil Med; 2013 Aug; 178(8):e954-5. PubMed ID: 23929062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
    Lopes da Silva J; Luiz Renna N; Paulino E; de Melo AC
    Int J Gynecol Cancer; 2015 Jun; 25(5):786-91. PubMed ID: 25790041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
    Duhil de Bénazé G; Pacquement H; Faure-Conter C; Patte C; Orbach D; Corradini N; Berger C; Sudour-Bonnange H; Vérité C; Martelli H; Fresneau B
    Eur J Cancer; 2018 Mar; 91():30-37. PubMed ID: 29331749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.